Minimally invasive techniques for improving the appearance of the aging face

Expert Review of Dermatology

Volumn 2, Issue 4, 2007, Pages 427-435

  Bogle, Melissa A ^a  

^a The Laser and Cosmetic Surgery Center of Houston   (United States)

Author keywords

Aging face; Botulinum; Fillers; Fractional photothermolysis; Laser; Light; Photoaging; Radiofrequency; Rejuvenation; Resurfacing

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; COLLAGEN; COSMETIC; FAT; HYALURONIC ACID; HYDROXYAPATITE; POLY(METHYL METHACRYLATE); POLYLACTIC ACID; RELOXIN; SILICONE; UNCLASSIFIED DRUG;

AGING; CLINICAL TRIAL; DERMOEPIDERMAL JUNCTION; ESTHETIC SURGERY; FACE MUSCLE; FACE PROFILE; FACE SURGERY; FACIAL EXPRESSION; FOREHEAD; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; LOW LEVEL LASER THERAPY; MAXILLOFACIAL PROSTHESIS; MINIMALLY INVASIVE SURGERY; MUSCLE RELAXATION; PHOTOTHERAPY; PRIORITY JOURNAL; PULSED DYE LASER; RADIOFREQUENCY ABLATION; REVIEW; SCAR FORMATION; SKIN ATROPHY; SKIN CARE; SKIN WATER LOSS; SUBCUTANEOUS TISSUE; WRINKLE;

EID: 34547925211     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/17469872.2.4.427     Document Type: Review

References (47)

1. Roenigk HH Jr. Treatment of the aging face. Dermatol. Clin. 13, 245-261 (1995).
2. Fedok FG. The aging face. Facial Plast. Surg. 12, 107-115 (1996).
3. Yaar M, Gilchrest BA. Cellular and molecular mechanisms of cutaneous aging. Dermatol. Surg. Oncol. 16, 915-922 (1990).
4. Taylor CR, Stern RS, Leyden JJ, Gilchrest BA. Photoaging, photodamage, and photoprotection. J. Am. Acad. Dermatol. 22, 1-15 (1990).
5. Kligman AM, Baker TJ, Gordon HL. Long-term histologic follow-up of phenol face peels. Plast. Recontr. Surg. 75, 652-659 (1985).
6. Bailey AJ, Robins SP, Balin G. Biological significance of the intermolecular crosslinks of collagen. Nature 251, 105-109 (1974).
7. Daly CH, Odland GF. Age-related changes in the mechanical properties of human skin. J. Invest. Dermatol. 73, 84-87 (1979).
8. Miyahara T, Murai A, Tanaka T, Shiozawa S, Kameyama M. Age-related differences in human skin collagen. J. Gerontol. 37, 651-655 (1982).
9. Leveque JL, Corcuff P, de Rigal J, Agache P. In vivo studies of the evaluation of physical properties of the human skin with age. Int. J. Dermatol. 23, 322-329 (1984).
10. Ellis DA, Ward DK. The aging face. J. Otolaryngol. 15, 217-223 (1986).
11. Rubin LR, Mishriki Y, Lee G. Anatomy of the nasolabial fold: the keystone of the smiling mechanism. Plast. Reconstr. Surg. 83, 1-10 (1995).
12. Hamra ST. Repositioning the orbicularis oculi muscle in the composite rhytidectomy. Plast. Reconstr. Surg. 90, 14-22 (1992).
13. Yousif NJ. Changes of the mid-face with age. Clin. Plast. Surg. 22, 213-226 (1995).
14. Jancke JB, Wright WK. Studies on the support of the nasal tip. Arch. Otolaryngol. 93, 458-764 (1971).
15. Pessa JF. An algorithm of facial aging. Plast. Reconstr. Surg. 106, 479-488 (2000).
16. Carruthers A, Carruthers JA. Treatment of glabellar frown lines with C. botulinum A exotoxin. Dermatol. Surg. 1S, 17-21 (1992).
17. Carruthers A, Carruthers J. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol. Surg. 31, 271-275 (2005).
18. Carruthers J, Fagren S, Matarasso S. Consensus recommendations for the use of botulinum toxin type A in facial aesthetics. Plast. Reconst. Surg. 114, 1S-22S (2004).
19. Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Int. Ophthalmol. Clin. 45, 123-131 (2005).
20. Flynn TC, Carruthers J, Carruthers A. Botulinum A treatment of the lower eyelid improves infraorbital rhytids and widens the eye. Dermatol. Surg. 27, 703-708 (2001).
21. Semchyshyn N, Sengelmann RD. Botulinum toxin treatment of perioral rhytids. Dermatol. Surg. 29, 490-495 (2003).
22. Beer K, Yolm M, Closter J. A double-blinded, placebo-controlled study of Botox for the treatment of subjects with chin rhytids. J. Drugs Dermatol. 4, 417-422 (2005).
23. Lemperle G, Romanon JJ, Busson M. Soft tissue augmentation with Artecoll: 10 year history, indications, techniques, and complications. Dermatol. Surg. 29, 573-587 (2003).
24. Matarasso S. The use of injectable collagens for aesthetic rejuvenation. Semin. Cutan. Med. Surg. 25, 151-157 (2006).
25. Lupo M. Hyaluronic acid fillers in facial rejuvenation. Semin. Cutan. Med. Surg. 25, 122-126 (2006).
26. Marmur ES, Phelps R, Goldberg DJ. Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J. Cosmet. Laser Ther. 6, 223-226 (2004).
27. Mayer R, Lightfoot M, Jung I. Preliminary evaluation of calcium hydroxytapatite as a transurethral bulking agent for stress urinary incontinence. Urology 57, 434-438 (2001).
28. Vleggar D, Bauer U. Facial enhancement and the European experience with Sculptra. J. Drugs Dermatol. 3, 542-547 (2004).
29. Burgess C, Quiroga R. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV associated facial lipoatrophy. J. Am. Acad. Dermatol. 2, 233-239 (2005).
30. Fulton JE, Parastouk N. Fat grafting. Dermatol. Clin. 19, 523-530 (2001).
31. Donofrio LM. Structural autologous lipoaugmentation: a pan-facial technique. Dermatol. Surg. 31, 1487-1495 (2000).
32. Hanke CW. Fat transplantation: indications, techniques, results. Dermatol. Surg. 26, 1106 (2000).
33. Bogle MA, Uebelhoer N, Weiss RA, Mayoral F, Kaminer MS. Evaluation of the multiple pass, low fluence technique for radiofrequency tightening of the lower face. Lasers Surg. Med. 39, 214-217 (2007).
34. Sadick NS, Makino Y. Selective electrothermolysis in aesthetic medicine: a review. Lasers Surg. Med. 34, 91-97 (2004).
35. Raulin C, Greve B, Grema H. IPI technology: a review. Lasers Surg. Med. 32, 78-87 (2003).
36. Uebelhoer NS, Bogle MA, Stewart B, Arndt KA, Dover JS. A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema. Dermatol. Surg. 33, 441-448 (2007).
37. Hirsch RJ, Dayan SH. Nonablative resurfacing. Facial Plast. Surg. 20, 57-61 (2004).
38. Weiss RA, McDaniel DH, Geronemus RG et al. Clinical experience with light-emitting diode (LED) photomodulation. Dermatol. Surg. 31, 1199-1205 (2005).
39. Geronemus RG. Fractional photothermolysis: current and future applications. Lasers Surg. Med. 38, 169-176 (2006).
40. Papadavid E, Katsambas A. Lasers for facial rejuvenation: a review. Int. J. Dermatol. 42, 480-487 (2003).
41. Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg. Med. 34, 426-438 (2004).
42. Bogle M, Arndt KA, Dover JS. Evaluation of plasma skin regeneration technology in low-energy full-facial rejuvenation. Arch. Dermatol. 143, 168-174 (2007).
43. Bogle M. Plasma skin regeneration technology. Skin Ther. Lett. 11, 7-9 (2006).
44. Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br. J. Dermatol. 142, 973-978 (2000).
45. Trelles MA, Rigau J, Velez M. LLLT and in vivo effects on mast cells. In: Lasers in Medicine and Dentistry. Simunovic Z (Ed.). VitaGraf, Croatia 169-186 (2000).
46. Weiss RA, McDaniel DH, Geronemus RG, Weiss MA, Clinical trial of a novel non-thermal LED array for reversal of photoaging: clinical, histologic, and surface profilometric results. Lasers Surg. Med. 36, 85-91 (2005).
47. Weiss RA, McDaniel DH, Geronemus RG. Review of nonablative photorejuvenation: reversal of the aging effects of the sun and environmental damage using laser and light sources. Semin. Cutan. Med. Surg. 22, 93-106 (2003).